These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35188568)

  • 1. Correction to 'An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb'.
    Nucleic Acids Res; 2022 Mar; 50(5):2994. PubMed ID: 35188568
    [No Abstract]   [Full Text] [Related]  

  • 2. An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb.
    Shortridge MD; Wille PT; Jones AN; Davidson A; Bogdanovic J; Arts E; Karn J; Robinson JA; Varani G
    Nucleic Acids Res; 2019 Feb; 47(3):1523-1531. PubMed ID: 30481318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent HIV-1 TAR Regulates 7SK-responsive P-TEFb Target Genes and Targets Cellular Immune Responses in the Absence of Tat.
    Eilebrecht S; Benecke BJ; Benecke AG
    Genomics Proteomics Bioinformatics; 2017 Oct; 15(5):313-323. PubMed ID: 29037489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribose) polymerase-1 is a negative regulator of HIV-1 transcription through competitive binding to TAR RNA with Tat.positive transcription elongation factor b (p-TEFb) complex.
    Parent M; Yung TM; Rancourt A; Ho EL; Vispé S; Suzuki-Matsuda F; Uehara A; Wada T; Handa H; Satoh MS
    J Biol Chem; 2005 Jan; 280(1):448-57. PubMed ID: 15498776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AFF4 binding to Tat-P-TEFb indirectly stimulates TAR recognition of super elongation complexes at the HIV promoter.
    Schulze-Gahmen U; Lu H; Zhou Q; Alber T
    Elife; 2014 Apr; 3():e02375. PubMed ID: 24843025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.
    Fong YW; Zhou Q
    Mol Cell Biol; 2000 Aug; 20(16):5897-907. PubMed ID: 10913173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA.
    D'Orso I; Jang GM; Pastuszak AW; Faust TB; Quezada E; Booth DS; Frankel AD
    Mol Cell Biol; 2012 Dec; 32(23):4780-93. PubMed ID: 23007159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat.
    Muniz L; Egloff S; Ughy B; Jády BE; Kiss T
    PLoS Pathog; 2010 Oct; 6(10):e1001152. PubMed ID: 20976203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1.
    Zhang J; Tamilarasu N; Hwang S; Garber ME; Huq I; Jones KA; Rana TM
    J Biol Chem; 2000 Nov; 275(44):34314-9. PubMed ID: 10944537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR.
    Sedore SC; Byers SA; Biglione S; Price JP; Maury WJ; Price DH
    Nucleic Acids Res; 2007; 35(13):4347-58. PubMed ID: 17576689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
    Richter S; Cao H; Rana TM
    Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1.
    Yedavalli VS; Benkirane M; Jeang KT
    J Biol Chem; 2003 Feb; 278(8):6404-10. PubMed ID: 12458222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4.
    Gu J; Babayeva ND; Suwa Y; Baranovskiy AG; Price DH; Tahirov TH
    Cell Cycle; 2014; 13(11):1788-97. PubMed ID: 24727379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human immunodeficiency virus type 1 Tat-like arginine-rich RNA-binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA-mediated inactivation of P-TEFb.
    Yik JH; Chen R; Pezda AC; Samford CS; Zhou Q
    Mol Cell Biol; 2004 Jun; 24(12):5094-105. PubMed ID: 15169877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tat acetylation modulates assembly of a viral-host RNA-protein transcription complex.
    D'Orso I; Frankel AD
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3101-6. PubMed ID: 19223581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
    Zhou Q; Chen D; Pierstorff E; Luo K
    EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of HIV-1 Tat-mediated transactivation.
    Richter SN; Palù G
    Curr Med Chem; 2006; 13(11):1305-15. PubMed ID: 16712471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat.
    Brès V; Gomes N; Pickle L; Jones KA
    Genes Dev; 2005 May; 19(10):1211-26. PubMed ID: 15905409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A real-time view of the TAR:Tat:P-TEFb complex at HIV-1 transcription sites.
    Molle D; Maiuri P; Boireau S; Bertrand E; Knezevich A; Marcello A; Basyuk E
    Retrovirology; 2007 May; 4():36. PubMed ID: 17537237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.